Overview

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

Status:
Completed

Trial end date:
2021-04-26

Target enrollment:

Participant gender:

Summary

The purpose of the study is to assess the safety, tolerability, and pharmacokinetics (PK) of Staccato alprazolam in healthy Japanese, Chinese, and Caucasian participants.

Phase:

Phase 1

Details

Lead Sponsor:

UCB Biopharma SRL

Treatments:

Alprazolam